GLO1 and endothelial dysfunction: In this setting, GLO1 overexpression ameliorated age-related endothelial dysfunction without changing conventional CVD risk factors such as body weight, blood pressure, glucose tolerance, or lipid metabolism, firmly indicating that GLO1 reduces glycative and oxidative stress and essentially ameliorates age-related endothelial dysfunction.